Close

Arrowhead Research (ARWR) Announces FDA Clinical Hold Placed on Heparc-2004 Study

Go back to Arrowhead Research (ARWR) Announces FDA Clinical Hold Placed on Heparc-2004 Study
ARROWHEAD RESEARCH (NASDAQ: ARWR) Delayed: 23.29 -0.49 (2.06%)
Previous Close $23.78    52 Week High $8.22 
Open $23.74    52 Week Low $3.07 
Day High $23.76    P/E N/A 
Day Low $22.89    EPS $-1.30 
Volume 807,165